{{Rsnum
|rsid=289747
|Gene=NLRC5
|Chromosome=16
|position=56990026
|Orientation=minus
|GMAF=0.3448
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=NLRC5
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.0 | 49.6 | 35.4
| HCB | 2.9 | 40.1 | 56.9
| JPT | 0.9 | 27.4 | 71.7
| YRI | 20.4 | 53.1 | 26.5
| ASW | 22.8 | 52.6 | 24.6
| CHB | 2.9 | 40.1 | 56.9
| CHD | 9.2 | 38.5 | 52.3
| GIH | 23.8 | 37.6 | 38.6
| LWK | 16.4 | 43.6 | 40.0
| MEX | 10.5 | 54.4 | 35.1
| MKK | 12.2 | 39.1 | 48.7
| TSI | 10.8 | 51.0 | 38.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=21859556
|Title=Association Study of Selected Genetic Polymorphisms and Occurrence of Venous Thromboembolism in Patients With Multiple Myeloma Who Were Treated With Thalidomide
}}

{{PMID Auto
|PMID=18787502
|Title=Genetic contributions to the development of retinopathy of prematurity.
|OA=1
}}

{{PMID Auto
|PMID=19682379
|Title=TagSNP transferability and relative loss of variability prediction from HapMap to an admixed population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}